UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Clinical cancer research, 2018-08, Vol.24 (15), p.3583-3592

2018

Volltextzugriff (PDF)

Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer

Experimental hematology & oncology, 2019-08, Vol.8 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

MOF-mediated acetylation of SIRT6 disrupts SIRT6-FOXA2 interaction and represses SIRT6 tumor-suppressive function by upregulating ZEB2 in NSCLC

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112939-112939, Article 112939

2023

Volltextzugriff (PDF)

Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification

Frontiers of medicine, 2024-08, Vol.18 (4), p.735-743

2024

Volltextzugriff (PDF)

Randomized controlled trial of an alternative drainage strategy vs routine chest tube insertion for postoperative pain after thoracoscopic wedge resection

BMC anesthesiology, 2022-01, Vol.22 (1), p.27-27, Article 27

2022

Volltextzugriff (PDF)

A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy

Frontiers in pharmacology, 2022-11, Vol.13, p.1044083-1044083

2022

Volltextzugriff (PDF)

Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study

Molecular oncology, 2023-05, Vol.17 (5), p.825-838

2023

Volltextzugriff (PDF)

Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules

Journal of nanobiotechnology, 2022-04, Vol.20 (1), p.172-172, Article 172

2022

Volltextzugriff (PDF)

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Journal of hematology and oncology, 2015-05, Vol.8 (1), p.54-54, Article 54

2015

Volltextzugriff (PDF)

Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients

Oncotarget, 2017-12, Vol.8 (67), p.111246-111257

2017

Volltextzugriff (PDF)

Wedge Resection of Pulmonary Nodules (≤2 cm):  A Consensus Statement by Specialists of Thoracic Surgery (2023 Edition)

Zhongguo fei ai za zhi, 2023-05, Vol.26 (5), p.338-347

2023

Volltextzugriff (PDF)

Three-dimensional computed tomography reconstruction in video-assisted thoracoscopic segmentectomy (DRIVATS): A prospective, multicenter randomized controlled trial

Frontiers in surgery, 2022-10, Vol.9, p.941582-941582

2022

Volltextzugriff (PDF)

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma

Frontiers in immunology, 2022-08, Vol.13, p.944812-944812

2022

Volltextzugriff (PDF)

Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial

JCI insight, 2022-01, Vol.7 (1)

2022

Volltextzugriff (PDF)

Proteomic characteristics of lung adenocarcinoma tumors that are small but highly invasive

Medicine Advances, 2023-12, Vol.1 (4), p.340-352

2023

Volltextzugriff (PDF)

Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy

BMJ Oncology, 2024-02, Vol.3 (1), p.e000128

2024

Volltextzugriff (PDF)

Graphic Evolution Witness the Development of Lung Cancer Translational Research

Zhongguo fei ai za zhi, 2016-06, Vol.19 (6), p.403-408

2016

Volltextzugriff (PDF)

A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer

Frontiers in oncology, 2020-09, Vol.10, p.1503-1503

2020

Volltextzugriff (PDF)

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer

European journal of cardio-thoracic surgery, 2008-07, Vol.34 (1), p.187-195

2008

Volltextzugriff (PDF)

The earlier, the better? A review of neoadjuvant immunotherapy in resectable non‐small‐cell lung cancer

Chronic diseases and translational medicine, 2022-06, Vol.8 (2), p.100-111

2022

Volltextzugriff (PDF)

Poor prognosis of intra‐tumoural TRBV6‐6 variants in EGFR‐mutant NSCLC: Results from the ADJUVANT‐CTONG1104 trial

Clinical and translational medicine, 2022-04, Vol.12 (4), p.e775-n/a

2022

Volltextzugriff (PDF)

Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy

Biomaterials, 2022-01, Vol.280, p.121250-121250, Article 121250

2022

Volltextzugriff (PDF)

Misdiagnosed desmoplastic small round cell tumor of the pleura: Case report and literature review

Journal of the Formosan Medical Association, 2014-01, Vol.113 (1), p.60-61

2014

Volltextzugriff (PDF)

Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics

Zhongguo fei ai za zhi, 2020-06, Vol.23 (6), p.532-540

2020

Volltextzugriff (PDF)

GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification

Advanced materials (Weinheim), 2024-01, Vol.36 (2), p.e2304098-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(56)
Humans
(36)
Lung Cancer
(29)
Oncology
(29)
Respiratory System
(19)
Chemotherapy
(16)
Cancer Therapies
(15)
Mutation
(15)
Female
(11)
Immunotherapy
(11)
Male
(11)
Technology
(11)
Tumors
(11)
Lung Neoplasms - Genetics
(10)
Middle Aged
(10)
Surgery
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Carcinoma, Non-Small-Cell Lung - Genetics
(9)
Metastasis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer

MOF-mediated acetylation of SIRT6 disrupts SIRT6-FOXA2 interaction and represses SIRT6 tumor-suppressive function by upregulating ZEB2 in NSCLC

Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification

Randomized controlled trial of an alternative drainage strategy vs routine chest tube insertion for postoperative pain after thoracoscopic wedge resection

A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy

Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study

Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients

Wedge Resection of Pulmonary Nodules (≤2 cm):  A Consensus Statement by Specialists of Thoracic Surgery (2023 Edition)

Three-dimensional computed tomography reconstruction in video-assisted thoracoscopic segmentectomy (DRIVATS): A prospective, multicenter randomized controlled trial

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma

Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial

Proteomic characteristics of lung adenocarcinoma tumors that are small but highly invasive

Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy

Graphic Evolution Witness the Development of Lung Cancer Translational Research

A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer

The earlier, the better? A review of neoadjuvant immunotherapy in resectable non‐small‐cell lung cancer

Poor prognosis of intra‐tumoural TRBV6‐6 variants in EGFR‐mutant NSCLC: Results from the ADJUVANT‐CTONG1104 trial

Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy

Misdiagnosed desmoplastic small round cell tumor of the pleura: Case report and literature review

Combination of Radiation Therapy and Immunotherapy for Non-small Cell Lung Cancer: Peer Exchange on Frontier Academic Topics

GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification

Suchergebnisse filtern